Elucidating the role of baicalein-enriched fraction to modulate ischemic stroke recovery in rat model
Ischemic stroke is presently the top two leading causes of mortality and long-term adult disability worldwide. Up to date, recombinant tissue plasminogen activator (rtPA) is the one and only approved drug for ischemic stroke therapy. The situation is even worse when this standard therapy has very na...
| 第一著者: | |
|---|---|
| フォーマット: | 学位論文 |
| 言語: | 英語 |
| 出版事項: |
2023
|
| 主題: | |
| オンライン･アクセス: | http://eprints.usm.my/59822/ |